Next Gen TB Test

Billions of people are infected, and millions of people die each year from tuberculosis, making it a significant public health issue. Current screening and testing methods are slow, complex, and insufficient to address the problem.

nanoRETE aims to help improve the world’s health by correctly detecting and treating TB infection and active disease to control the level of contagion in the environment. We are focused on delivering to the market the next generation of screening tests for tuberculosis that solve the problems of the current methods and advance the method to single point-of-care.

nanoRETE’s next generation TB test delivers:
•    High accuracy to deliver definitive results
•    80% reduction in test time
•    Lower cost to results

The nanoRETE screening test consists of a proprietary lateral flow kit that is quick and easy to use.